Cite
The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper.
MLA
Hill, Quentin A., et al. “The Prevention of Glucocorticoid‐induced Osteoporosis in Patients with Immune Thrombocytopenia Receiving Steroids: A British Society for Haematology Good Practice Paper.” British Journal of Haematology, vol. 185, no. 3, May 2019, pp. 410–17. EBSCOhost, https://doi.org/10.1111/bjh.15735.
APA
Hill, Q. A., Bagot, C., Kanis, J. A., Compston, J. E., Grainger, J. D., Thachil, J., Provan, D., Evans, G., Garg, M., & Bradbury, C. (2019). The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper. British Journal of Haematology, 185(3), 410–417. https://doi.org/10.1111/bjh.15735
Chicago
Hill, Quentin A., Catherine Bagot, John A. Kanis, Juliet E. Compston, John D. Grainger, Jecko Thachil, Drew Provan, Gillian Evans, Mamta Garg, and Charlotte Bradbury. 2019. “The Prevention of Glucocorticoid‐induced Osteoporosis in Patients with Immune Thrombocytopenia Receiving Steroids: A British Society for Haematology Good Practice Paper.” British Journal of Haematology 185 (3): 410–17. doi:10.1111/bjh.15735.